Filing Details

Accession Number:
0001493152-18-010994
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-06 14:37:31
Reporting Period:
2018-08-02
Accepted Time:
2018-08-06 14:37:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
764195 Vbi Vaccines Inc VBIV Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1701865 Francisco Diaz-Mitoma C/O Vbi Vaccines Inc.,
222 Third Street, Ste 2241
Cambridge, MA 02142
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, No Par Value Per Share Acquisiton 2018-08-02 3,000 $2.20 11,500 No 4 P Indirect See Footnote
Common Shares, No Par Value Per Share Acquisiton 2018-08-03 6,000 $2.10 17,500 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares, No Par Value Per Share 268,839 Direct
Common Shares, No Par Value Per Share 19,404 Indirect See Footnote
Footnotes
  1. Represents the weighted average price of shares purchased in multiple transactions at prices ranging from $2.19 to $2.219, inclusive. The reporting person undertakes to provide to VBI Vaccines Inc., any security holder of VBI Vaccines Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
  2. The common shares are held of record by F. Diaz-Mitoma Medicine Professional Corporation. As the President of such professional corporation, the reporting person has sole voting and dispositive power over the common shares held by the professional corporation.
  3. Represents the weighted average price of shares purchased in multiple transactions at prices ranging from $2.029 to $2.129, inclusive. The reporting person undertakes to provide to VBI Vaccines Inc., any security holder of VBI Vaccines Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
  4. The common shares are held of record by 1120962 Ontario Inc. As the President of such corporation that owns 100% of its voting securities, the reporting person has the power to vote and dispose of the common shares held by the corporation.